Use of focused light scattering techniques in biological applications
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
G01N-033/569
G01N-015/14
G01N-015/00
출원번호
US-0481618
(2014-09-09)
등록번호
US-9459252
(2016-10-04)
발명자
/ 주소
Gabriel, Don
출원인 / 주소
Invitrox, Inc.
대리인 / 주소
Andrews Kurth LLP
인용정보
피인용 횟수 :
0인용 특허 :
9
초록▼
Methods for using focused light scattering techniques for the optical sensing of biological particles suspended in a liquid medium are disclosed. The optical sensing enables one to characterize particles size and/or distribution in a given sample. This, in turn, allows one to identify the biological
Methods for using focused light scattering techniques for the optical sensing of biological particles suspended in a liquid medium are disclosed. The optical sensing enables one to characterize particles size and/or distribution in a given sample. This, in turn, allows one to identify the biological particles, determine their relative particle density, detect particle shedding, and identify particle aggregation. The methods are also useful in screening and optimizing drug candidates, evaluating the efficacy and dosage levels of such drugs, and in personalized medicine applications.
대표청구항▼
1. A method of identifying particle aggregation in a sample medium comprising: a) generating a first spectrum showing particle size and distribution for a sample medium which may or may not include a biological particle of interest, by passing the sample medium past a focused light beam formed by pa
1. A method of identifying particle aggregation in a sample medium comprising: a) generating a first spectrum showing particle size and distribution for a sample medium which may or may not include a biological particle of interest, by passing the sample medium past a focused light beam formed by passing a collimated light beam through an acceptance aperture to narrow the width of the beam, using focused light scattering techniques to prepare a spectrum showing particle size distribution from within the sample medium, where particle size is reflected by the location of one or more peaks on the spectrum, and the number of particles is reflected by the area under the curve of the peak, wherein the presence of a peak corresponding to the particle size of aggregated particles is indicative of the presence of an aggregate, wherein said focused light scattering techniques involve sensing single particles suspended in a sample medium when the sample medium is passed through a focused beam of light, such that, when the focused beam of light passes through the sample medium without being scattered by a particle, the beam passes on to a photodetector and the intensity is measured, wherein the focused beam is of a size such that a particle in the size range of 0.1 to 10 μm is sufficient to block all of the beam, or a significant enough part of the beam, so that the particle size can be measured, and when the beam is scattered, in whole or in part, by a particle, the intensity of the beam hitting the photodetector is altered, and the particle size and/or concentration are calculated using light-extinction, light-scattering detection, or both. 2. The method of claim 1, wherein the sample medium includes a biological particle which may or may not include a mutation associated with particle aggregation, further comprising incubating the sample medium with an active agent which promotes or inhibits aggregation of the biological particle in the absence of the mutation in the biological particle,wherein the development of, or lack of development of, particle aggregation provides information on the presence or absence of the mutation, as well as information on the activity, or lack of activity, of the active agent in promoting or inhibiting the aggregation of the biological particle. 3. The method of claim 2, wherein the biological particle is a platelet. 4. The method of claim 3, wherein the active agent is clopidogrel bisulfate. 5. A method of identifying particle aggregation in a sample medium comprising platelets obtained from a patient to which Clopidogrel bisulfate has been administered, comprising: a) adding a P2Y12 agonist to the medium in an amount that would cause platelet aggregation if the patient is non-responsive to Clopidogrel bisulfate, wherein the absence of platelet aggregation is indicative of the patient being responsive to Clopidogrel bisulfate, and the presence of platelet aggregation is indicative of the patient being non-responsive to Clopidogrel bisulfate, andb) generating a spectrum showing the particle size and distribution of the platelets using focused light scattering techniques to prepare a spectrum showing particle size distribution from within the sample medium, where particle size is reflected by the location of one or more peaks on the spectrum, and the number of particles is reflected by the area under the curve of the peak;wherein the presence of a peak corresponding to the particle size of aggregated platelets is indicative of the patient being non-responsive to Clopidogrel bisulfate, and wherein the absence of a peak corresponding to the particle size of aggregated platelets is indicative of the patient being responsive to Clopidogrel bisulfate,wherein said focused light scattering techniques involve sensing single particles suspended in a sample medium when the sample medium is passed through a focused beam of light, such that, when the focused beam of light passes through the sample medium without being scattered by a particle, the beam passes on to a photodetector and the intensity is measured, wherein the focused beam is of a size such that a particle in the size range of 0.1 to 10 μm is sufficient to block all of the beam, or a significant enough part of the beam, so that the particle size can be measured, and when the beam is scattered, in whole or in part, by a particle, the intensity of the beam hitting the photodetector is altered, and the particle size and/or concentration are calculated using light-extinction, light-scattering detection, or both. 6. The method of claim 5, wherein the P2Y12 agonist is adenosine diphosphate.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (9)
Yguerabide, Juan; Yguerabide, Evangelina E.; Kohne, David E.; Jackson, Jeffrey T., Analyte assay using particulate labels.
Hansen, Frans Ejner Rvan; Glensbjerg, Martin; Arnvidarson, Borkur; Jeppesen, Jesper Myron, Method and a system for determination of particles in a liquid sample.
Rodriguez Carlos M. ; Cano Jose M. ; Carrillo Barbara ; Gordon Kristie M. ; Horton Allan F. ; Paul Ronald D. ; Wells Mark A. ; Wyatt James L., Method and apparatus for analyzing cells in a whole blood sample.
Garcia-Rubio, Luis Humberto; Potter, Robert; Leparc, German; Orton, Sharyn; Mattley, Yvette; Bacon, Christina, Spectrophotometric method and apparatus for the cross-matching of platelets.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.